Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response

PLoS Biology(2022)10.1371/journal.pbio.3001851Source: DataRank Database

Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response is a research paper published in PLoS Biology (2022). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 4.84)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Arjit Vijey Jeyachandran,Yijie Wang ORCID,Joseph Ignatius Irudayam,Sebastian Castillo Cario,Chandani Sen ORCID

Live enrichment

PubMed:36346780 PMC:PMC9642871 OpenAlex:https://openalex.org/W4308578034

Broad Stem Cell Research Center

Grant: OCRC #20-15

National Institutes of Health

Grant: 1R01EY032149-01

Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection

National Institute of Health

Grant: 5R01AI163216-02

Developing three-dimensional antisense oligonucleotide drugs against COVID-19

National Institutes of Health

Grant: 1R01DK132735-01

Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity

National Institute of Health

Grant: 1R01CA208303

National Institutes of Health

Grant: R01AI145044

National Institutes of Health

Grant: U19AI149504

NCI NIH HHS

Grant: R01 CA208303

NIDDK NIH HHS

Grant: R01 DK132735

NEI NIH HHS

Grant: R01 EY032149

NIAID NIH HHS

Grant: R01 AI163216

NCI NIH HHS

Grant: P30 CA016042

NIAID NIH HHS

Grant: R01 AI140718

National Institutes of Health

Grant: 5U19AI149504-03

(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV

National Institutes of Health

Grant: 5R01CA208303-03

Developing a targeted chemoprevention strategy for Non-Small Cell Lung Cancer

National Institutes of Health

Grant: 5R01AI145044-05

B-cell-specific transduction for anti-HIV antibody and B-cell receptor expression

David Geffen School of Medicine, University of California, Los Angeles

UCLA W.M. Keck Foundation COVID-19 Research Award

The Tata Institute for Genetics and Society, India

FWCI

4.84

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001851&type=printable

publisherhttps://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001851&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pbio.3001851

journalhttps://doi.org/10.1371/journal.pbio.3001851

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36346780

Fields of Study

Hippo pathway signaling and YAP/TAZCell death mechanisms and regulation0301 basic medicine03 medical and health sciencesHumansCOVID-19SARS-CoV-2Hippo Signaling PathwayAntiviral AgentsSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2Hippo Signaling PathwayAntiviral AgentsHumans

Keywords

BiologyVirologyHost (biology)Hippo signaling pathwaySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusCoronavirus disease 2019 (COVID-19)Signal transductionGeneticsInfectious disease (medical specialty)570Biomedical and clinical sciencesCoronaviruses610Medical and Health SciencesAntiviral AgentsArticleCoronaviruses Therapeutics and Interventionsveterinary and food sciences2.1 Biological and endogenous factorsHumansLungAgriculturalAgricultural and Veterinary SciencesSARS-CoV-2COVID-19Biological SciencesStem Cell ResearchCoronaviruses Disparities and At-Risk PopulationsEmerging Infectious DiseasesInfectious DiseasesGood Health and Well BeingMedical MicrobiologyInfectionDevelopmental BiologyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being